Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis

Molecular Therapy

Volumn 23, Issue 1, 2015, Pages 79-88

  Chen, Chiu Ling ^a   Wu, Jaw Ching ^b   Chen, Guan Yu ^a   Yuan, Pei Hsiang ^a   Tseng, Yen Wen ^a   Li, Kuei Chang ^a   Hwang, Shiaw Min ^c   Hu, Yu Chen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; MICRORNA; MICRORNA 122; MICRORNA 151; PROTEIN BCL W; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RNA; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; VIRUS VECTOR; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; APOPTOSIS REGULATORY PROTEIN; BCL2L2 PROTEIN, HUMAN; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; MEMBRANE PROTEIN; MIRN122 MICRORNA, HUMAN; MIRN151 MICRORNA, HUMAN; PROTEIN KINASE P60; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 1; SECRETASE;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BACULOVIRIDAE; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LUNG METASTASIS; METASTASIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL MOTION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; INTRALESIONAL DRUG ADMINISTRATION; LIVER TUMOR; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; PROMOTER REGION; REPORTER GENE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BACULOVIRIDAE; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS; MEMBRANE PROTEINS; MICE; MICE, NUDE; MICRORNAS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR ALPHA; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84920646226     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2014.126     Document Type: Article

References (49)

1. Wong, CC, Wong, CM, Au, SL and Ng, IO (2010). RhoGTPases and Rho-effectors in hepatocellular carcinoma metastasis: ROCK N'Rho move it. Liver Int 30: 642-656.
2. Garzon, R, Marcucci, G and Croce, CM (2010). Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9: 775-789.
3. Bai, S, Nasser, MW, Wang, B, Hsu, SH, Datta, J, Kutay, H et al. (2009). MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 284: 32015-32027.
4. Lin, CJ, Gong, HY, Tseng, HC, Wang, WL and Wu, JL (2008). miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 375: 315-320.
5. Tsai, WC, Hsu, PW, Lai, TC, Chau, GY, Lin, CW, Chen, CM et al. (2009). MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49: 1571-1582.
6. Fornari, F, Gramantieri, L, Giovannini, C, Veronese, A, Ferracin, M, Sabbioni, S et al. (2009). MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 69: 5761-5767.
7. Ding, J, Huang, S, Wu, S, Zhao, Y, Liang, L, Yan, M et al. (2010). Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 12: 390-399.
8. Lu, CH, Chang, YH, Lin, SY, Li, KC and Hu, YC (2013). Recent progresses in gene delivery-based bone tissue engineering. Biotechnol Adv 31: 1695-1706.
9. Liao, YH, Chang, YH, Sung, LY, Li, KC, Yeh, CL, Yen, TC et al. (2014). Osteogenic differentiation of adipose-derived stem cells and calvarial defect repair using baculovirus-mediated co-expression of BMP-2 and miR-148b. Biomaterials 35: 4901-4910.
10. Yeh, TS, Fang, YH, Lu, CH, Chiu, SC, Yeh, CL, Yen, TC et al. (2014). Baculovirus-transduced, VEGF-expressing adipose-derived stem cell sheet for the treatment of myocardium infarction. Biomaterials 35: 174-184.
11. Lin, J, Teo, S, Lam, DH, Jeyaseelan, K and Wang, S (2012). MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme. Cell Death Dis 3: e398.
12. Chen, CL, Luo, WY, Lo, WH, Lin, KJ, Sung, LY, Shih, YS et al. (2011). Development of hybrid baculovirus vectors for artifcial MicroRNA delivery and prolonged gene suppression. Biotechnol Bioeng 108: 2958-2967.
13. Suzuki, H, Tamai, N, Habu, Y, Chang, MO and Takaku, H (2008). Suppression of hepatitis C virus replication by baculovirus vector-mediated short-hairpin RNA expression. FEBS Lett 582: 3085-3089.
14. Wang, S and Balasundaram, G (2010). Potential cancer gene therapy by baculoviral transduction. Curr Gene Ther 10: 214-225.
15. Luo, WY, Shih, YS, Hung, CL, Lo, KW, Chiang, CS, Lo, WH et al. (2012). Development of the hybrid Sleeping Beauty: baculovirus vector for sustained gene expression and cancer therapy. Gene Ther 19: 844-851.
16. Sung, LY, Chen, CL, Lin, SY, Hwang, SM, Lu, CH, Li, KC et al. (2013). Enhanced and prolonged baculovirus-mediated expression by incorporating recombinase system and in cis elements: a comparative study. Nucleic Acids Res 41: e139.
17. Turunen, TA, Laakkonen, JP, Alasaarela, L, Airenne, KJ and Ylä-Herttuala, S (2014). Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye. J Gene Med 16: 40-53.
18. Ebert, MS and Sharp, PA (2010). Emerging roles for natural microRNA sponges. Curr Biol 20: R858-R861.
19. Lin, CY, Chang, YH, Lin, KJ, Yen, TC, Tai, CL, Chen, CY et al. (2010). The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells. Biomaterials 31: 3222-3230.
20. Yang, MH, Chen, CL, Chau, GY, Chiou, SH, Su, CW, Chou, TY et al. (2009). Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 50: 1464-1474.
21. Ma, L, Liu, J, Shen, J, Liu, L, Wu, J, Li, W et al. (2010). Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther 9: 554-561.
22. Suzuki, T, Oo Chang, M, Kitajima, M and Takaku, H (2010). Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells. Cell Mol Immunol 7: 440-446.
23. Luo, WY, Shih, YS, Lo, WH, Chen, HR, Wang, SC, Wang, CH et al. (2011). Baculovirus vectors for antiangiogenesis-based cancer gene therapy. Cancer Gene Ther 18: 637-645.
24. Chung, KH, Hart, CC, Al-Bassam, S, Avery, A, Taylor, J, Patel, PD et al. (2006). Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res 34: e53.
25. Brown, BD and Naldini, L (2009). Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet 10: 578-585.
26. Ebert, MS and Sharp, PA (2010). MicroRNA sponges: progress and possibilities. RNA 16: 2043-2050.
27. Ebert, MS, Neilson, JR and Sharp, PA (2007). MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4: 721-726.
28. Bak, RO, Hollensen, AK and Mikkelsen, JG (2013). Managing microRNAs with vector-encoded decoy-type inhibitors. Mol Ther 21: 1478-1485.
29. Blobel, CP (2005). ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6: 32-43.
30. Tognon, CE and Sorensen, PH (2012). Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy. Expert Opin Ther Targets 16: 33-48.
31. Posern, G and Treisman, R (2006). Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol 16: 588-596.
32. Zhang, Y, Wang, R, Du, W, Wang, S, Yang, L, Pan, Z et al. (2013). Downregulation of miR-151-5p contributes to increased susceptibility to arrhythmogenesis during myocardial infarction with estrogen deprivation. PLoS One 8: e72985.
33. Sibley, CR, Seow, Y and Wood, MJ (2010). Novel RNA-based strategies for therapeutic gene silencing. Mol Ther 18: 466-476.
34. Liu, Y, Cai, H, Liu, J, Fan, H, Wang, Z, Wang, Q et al. (2013). A miR-151 binding site polymorphism in the 3'-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma. Biochem Biophys Res Commun 432: 660-665.
35. Yang, X, Marcucci, K, Anguela, X and Couto, LB (2013). Preclinical evaluation of an anti-HCV miRNA cluster for treatment of HCV infection. Mol Ther 21: 588-601.
36. Noguchi, S, Iwasaki, J, Kumazaki, M, Mori, T, Maruo, K, Sakai, H et al. (2013). Chemically modifed synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo. Mol Ther 21: 1204-1211.
37. Gebert, LF, Rebhan, MA, Crivelli, SE, Denzler, R, Stoffel, M and Hall, J (2014). Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res 42: 609-621.
38. Borel, F, Kay, MA and Mueller, C (2014). Recombinant AAV as a platform for translating the therapeutic potential of RNA interference. Mol Ther 22: 692-701.
39. Amendola, M, Passerini, L, Pucci, F, Gentner, B, Bacchetta, R and Naldini, L (2009). Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform. Mol Ther 17: 1039-1052.
40. Balakrishnan, B and Jayandharan, GR (2014). Basic biology of adeno-associated virus (AAV) vectors used in gene therapy. Curr Gene Ther (epub ahead of print) (doi:10.2174/1566523214666140302193709).
41. Nowrouzi, A, Penaud-Budloo, M, Kaeppel, C, Appelt, U, Le Guiner, C, Moullier, P et al. (2012). Integration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver. Mol Ther 20: 1177-1186.
42. Rothe, M, Modlich, U and Schambach, A (2013). Biosafety challenges for use of lentiviral vectors in gene therapy. Curr Gene Ther 13: 453-468.
43. Donsante, A, Miller, DG, Li, Y, Vogler, C, Brunt, EM, Russell, DW et al. (2007). AAV vector integration sites in mouse hepatocellular carcinoma. Science 317: 477.
44. Airenne, KJ, Hu, YC, Kost, TA, Smith, RH, Kotin, RM, Ono, C et al. (2013). Baculovirus: an insect-derived vector for diverse gene transfer applications. Mol Ther 21: 739-749.
45. Chen, CY, Lin, CY, Chen, GY and Hu, YC (2011). Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications. Biotechnol Adv 29: 618-631.
46. Wu, Q, Xu, F, Fang, L, Xu, J, Li, B, Jiang, Y et al. (2013). Enhanced immunogenicity induced by an alphavirus replicon-based pseudotyped baculovirus vaccine against porcine reproductive and respiratory syndrome virus. J Virol Methods 187: 251-258.
47. Hackett, PB, Largaespada, DA and Cooper, LJ (2010). A transposon and transposase system for human application. Mol Ther 18: 674-683.
48. O'Reilly, D, Miller, L and Luckow, V (1992). Baculovirus Expression Vectors: A Laboratory Manual. W.H. Freeman and Co: New York.
49. Zhou, Q, Anderson, C, Zhang, H, Li, X, Inglis, F, Jayagopal, A et al. (2014). Repression of choroidal neovascularization through actin cytoskeleton pathways by microRNA-24. Mol Ther 22: 378-389.